To delve deeper into the role of CDK4 and CDK6, we conducted a protein-level analysis involving one glial cell line (SVG-p12) and three GBM cell lines (U-87-MG, GBM8401, and GL261). The gene discussed is CDK6; the disease is glioblastoma.